UnknownPHASE2, PHASE3NCT00091234

Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Studying Acute basophilic leukemia

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: Sergio Amadori, MD
EORTC - AZIENDA OSPEDALLERA UNIVERSITARIA - POLICLINICO TOR VERGATA, IT
Intervention: gemtuzumab ozogamicin(drug)
Enrollment: 279 enrolled
Eligibility: 61 years · All sexes
Timeline: 2004

Study locations (30)

Ziekenhuis Netwerk Antwerpen Middelheim, Antwerp, Belgium
AZ Sint-Jan, Bruges, Belgium
Institut Jules Bordet, Brussels, Belgium
Hopital Universitaire Erasme, Brussels, Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
CHU Liege - Domaine Universitaire du Sart Tilman, Liège, Belgium
Centre Hospitalier Peltzer-La Tourelle, Verviers, Belgium
Ospedale S Donato, USL-8, Arezzo Cap, Italy
Universita Degli Studi di Bari, Bari, Italy
Universita Di Brescia, Brescia, Italy
Ospedale Binaghi, Cagliari, Italy
Ospedale Oncologico A. Businco, Cagliari, Italy
Ospedale Regionale A Pugliese, Cantanzaro, Italy
Ospedale Ferrarotto, Catania, Italy
Ospedale Regionale A. Pugliese, Catanzaro, Italy
+15 more locations on ClinicalTrials.gov

Collaborators

Gruppo Italiano Malattie EMatologiche dell'Adulto

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00091234 on ClinicalTrials.gov

Other trials for Acute basophilic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute basophilic leukemia →

← Back to all trials